|
|
Volumn 7 Suppl 2, Issue , 2005, Pages
|
|
Preclinical data with bortezomib in lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
APOPTOSIS;
CELL CULTURE;
DRUG EFFECT;
DRUG INTERACTION;
GENE EXPRESSION REGULATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
PATHOLOGY;
PATHOPHYSIOLOGY;
REVIEW;
SMALL CELL CARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
BORONIC ACIDS;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SMALL CELL;
DRUG INTERACTIONS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LUNG NEOPLASMS;
PROTEASE INHIBITORS;
PYRAZINES;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
|
EID: 33644700435
PISSN: 15257304
EISSN: None
Source Type: Journal
DOI: 10.3816/clc.2005.s.008 Document Type: Review |
|
Times cited : (26)
|
|
References (70)
|
